InsidersTradesSigma
基于 2 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Discover the detailed record of transactions filed by Springstubb Brendan B. Officer active across 1 company, notably Evolent Health, Inc.. Cumulatively, 5 reports have been recorded. Breakdown: 2 buys · 0 sell. Total volume traded: €162k. History available since 3 March 2025. The latest transaction was disclosed on 4 June 2026 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 条申报中的 5 条
Springstubb Brendan B is a declarant linked to Evolent Health, Inc., where he is a Director. The record contains 5 filings in total, and the 5 sampled filings run from 2025-03-05 to 2026-06-08, with EUR 161851 of purchases and EUR 0 of sales; the modal transaction nature is Attribution.